A detailed history of Stratos Wealth Partners, Ltd. transactions in Viking Therapeutics, Inc. stock. As of the latest transaction made, Stratos Wealth Partners, Ltd. holds 3,254 shares of VKTX stock, worth $172,266. This represents 0.0% of its overall portfolio holdings.

Number of Shares
3,254
Holding current value
$172,266
% of portfolio
0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 17, 2024

BUY
$49.84 - $70.47 $162,179 - $229,309
3,254 New
3,254 $206,000
Q1 2024

Apr 16, 2024

BUY
$17.4 - $94.5 $54,548 - $296,257
3,135 New
3,135 $257,000
Q2 2018

Aug 13, 2018

SELL
$3.88 - $12.74 $368 - $1,210
-95 Closed
0 $0
Q1 2018

May 10, 2018

BUY
$4.11 - $6.93 $390 - $658
95 New
95 $0

Others Institutions Holding VKTX

About Viking Therapeutics, Inc.


  • Ticker VKTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 76,688,496
  • Market Cap $4.06B
  • Description
  • Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. The company's lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß), which is in Phase IIb clinical trial...
More about VKTX
Track This Portfolio

Track Stratos Wealth Partners, Ltd. Portfolio

Follow Stratos Wealth Partners, Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Stratos Wealth Partners, Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Stratos Wealth Partners, Ltd. with notifications on news.